Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX, INC | Chief Strategy Officer | Common Stock | 176K | $1.59M | $9.02 | Aug 23, 2024 | Direct |
OCULAR THERAPEUTIX, INC | Chief Strategy Officer | Stock Option (Right to Buy) | 245K | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUL | OCULAR THERAPEUTIX, INC | Aug 23, 2024 | 1 | -$16.5K | 4 | Aug 27, 2024 | Chief Strategy Officer |
OCUL | OCULAR THERAPEUTIX, INC | May 23, 2024 | 1 | -$13.3K | 4 | May 28, 2024 | Chief Strategy Officer |
OCUL | OCULAR THERAPEUTIX, INC | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | Chief Strategy Officer |
OCUL | OCULAR THERAPEUTIX, INC | Feb 21, 2024 | 0 | $0 | 3 | Feb 26, 2024 | Chief Strategy Officer |